Medicare Compliance & Reimbursement
ASSAULT CONTINUES ON DRUGMAKER RECORDKEEPING RULE
States call on CMS to withdraw controversial pharma reg. Drugmakers will have to go back to the drawing board when it comes to assessing how long they're obliged to keep pricing records if state fraud fighters get their way. Massachusetts Attorney General Tom Reilly Oct. 28 called on Department of Health and Human Services Secretary Tommy Thompson and Centers for Medicare & Medicaid Services chief Tom Scully to immediately withdraw the Aug. 29 final rule that allows pharmaceutical companies to destroy documents relating to the Medicaid drug rebate program after three years. Reilly was joined by AGs in 44 other states; Minnesota AG Mike Hatch is working on a separate letter opposing the rule. The AGs maintain that the rule would permit drugmakers to destroy documents that otherwise would serve as valuable evidence in fraud cases. And they're not alone in their opposition to the reg - Sen. Charles Grassley (R-IA) also has made his dislike of the rule clear, arguing that it would put a damper on whistleblower suits. Lesson Learned: Increasing resistance to the recordkeeping rule could run it off the tracks before its Jan. 1, 2004 effective date arrives.
Medicare Compliance & Reimbursement
- Rehab:
PROVIDERS GRAPPLING WITH INCOMING RULE
Rule could put some IRFs out of business. Now that the comment period has ended for [...] - Physicians:
CMS ANNOUNCES RATE CUT, BUT CONGRESS MAY REVERSE
Physicians are slated to receive a 4.5 percent cut in Medicare reimbursement under a final [...] - Home Health:
HHAs Preparing For M0175 Recoupments This Spring
Millions of dollars in takebacks based on patient hospital stays are on agencies' horizons. Despite [...] - Long-Term Care:
THREE-DAY HOSPITAL-STAY RULE STILL VEXES OIG
Nursing homes could face overpayment demands. Are skilled nursing facilities across the country inappropriately collecting [...] - Labs:
WHAT LAB SURVEYORS ARE LOOKING FOR
CLIA inspectors offer insider tips for a smoother survey. Laboratory inspectors around the nation are [...] - Pharmaceuticals:
CMS REVS UP STATES ON MEDICARE DRUG DISCOUNT CARDS
Program will go live next spring. Even though legislation establishing a Medicare-endorsed prescription drug program [...] - Home Health:
Bidding In, Copays Out In Latest Medicare Legislation
Home care provisions in flux.
Congressional leaders are stepping up the intensity of Medicare legislation negotiations, [...] - Pharmaceuticals:
ASSAULT CONTINUES ON DRUGMAKER RECORDKEEPING RULE
States call on CMS to withdraw controversial pharma reg. Drugmakers will have to go back to [...] - Rehab:
CAPS COULD SPAWN NEW ERA IN HOSPITAL-SNF RELATIONSHIPS
As long as the therapy caps are in place, many patients will be shuffled to [...] - Medicaid:
TX PROVIDERS MAY FACE IMD RECOUPMENTS
Ongoing OIG probe addresses Medicaid payments for IMD residents.
In its latest attempt to assess whether [...] - BILL WATCH
The following bill was introduced in the House: HR 3382. A bill to amend titles [...]
